IP Library Granted Patent US 7,504,229
Granted Patent B2
US 7,504,229 · App. 11/231,104 · Granted Mar 17, 2009

Methods for detecting

Assignee: Monsanto Technology LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,229
App. No.
11/231,104
Granted
Mar 17, 2009
Kind
B2
Abstract

Disclosed are Bacillus thuringiensis strains comprising novel crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae ( Tribolium castaneum ) and Japanese beetle larvae ( Popillia japonica ). Also disclosed are novel B. thuringiensis crystal toxin genes, designated cryET33 and cryET34, which encode the colepteran-toxic crystal proteins, CryET33 (29-kDa) crystal protein, and the cryET34 gene encodes the 14-kDa CryET34 crystal protein. The CryET33 and CryET34 crystal proteins are toxic to red flour beetle larvae and Japanese beetle larvae. Also disclosed are methods of making and using transgenic cells comprising the novel nucleic acid sequences of the invention.

Claims (10)

1. A purified antibody that binds to a CryET33 peptide, wherein the CryET33 peptide is SEQ ID NO:3.

2. The purified antibody of claim 1 generated by using a peptide according to SEQ ID NO:3 as an immunogen.

3. The purified antibody of claim 1 produced by a hybridoma, wherein a peptide according to SEQ ID NO:3 is used to generate the hybridoma producing the antibody.

4. A method for detecting a CryET33 peptide in a biological sample, comprising the steps of:

(a) obtaining a biological sample suspected of containing the peptide;

(b) contacting the sample with an antibody of claim 1 , that binds to the peptide, under conditions effective to allow the formation of complexes; and

(c) detecting the complexes so formed.

5. The method of claim 4 , wherein the antibody is generated by using a peptide according to SEQ ID NO:3 as an immunogen.

6. An immunodetection kit comprising, in suitable container means, an antibody of claim 1 that binds to a CryET33 peptide, and an immunodetection reagent

7. The immunodetection kit of claim 6 , wherein the antibody is generated by using a peptide of SEQ ID NO:3 as an immunogen.

Continuity (4)
Division 0994997200 · Sep 10, 2001
Division 0914799200
Continuation In Part 0871890500 · Sep 24, 1996
Related Publication 20060051822A1 · Mar 9, 2006